Dexibuprofen lysine

Drug Profile

Dexibuprofen lysine

Alternative Names: L 669455; MK 233

Latest Information Update: 15 Aug 2002

Price : $50

At a glance

  • Originator Merck & Co
  • Class Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Headache; Inflammation; Pain

Most Recent Events

  • 08 Jun 1999 A study has been added to the Advances in the treatment of nausea and migraine therapeutic trials section
  • 23 Mar 1999 Investigation in Headache in USA (Unknown route)
  • 23 Mar 1999 Investigation in Pain in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top